[
  {
    "ts": "2025-09-02T13:25:28+00:00",
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings",
    "summary": "ClearBridge Investments, an investment management company, released its “ClearBridge All Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, growth stocks led the stock market to rebound from tariff uncertainty. The benchmark Russell 3000 Growth Index performed better as risk-on sentiment took hold, rising […]",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-slid-132528317.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "107dca43-1c01-3b68-9bb5-79d9e70ef24f",
      "content": {
        "id": "107dca43-1c01-3b68-9bb5-79d9e70ef24f",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings",
        "description": "",
        "summary": "ClearBridge Investments, an investment management company, released its “ClearBridge All Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, growth stocks led the stock market to rebound from tariff uncertainty. The benchmark Russell 3000 Growth Index performed better as risk-on sentiment took hold, rising […]",
        "pubDate": "2025-09-02T13:25:28Z",
        "displayTime": "2025-09-02T13:25:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/d61abed3f7567688cd16b4e2785171ec",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/73o67FZt31QGX4RW9oCwEA--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d61abed3f7567688cd16b4e2785171ec.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eKC281F2zJCXGmB_sO5saA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d61abed3f7567688cd16b4e2785171ec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-slid-132528317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-slid-132528317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-02T13:00:00+00:00",
    "headline": "Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases",
    "summary": "LA JOLLA, Calif., September 02, 2025--Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals",
    "url": "https://finance.yahoo.com/news/enlaza-therapeutics-announces-strategic-collaboration-130000070.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "6b5c3d47-47ec-3907-8654-881a64296321",
      "content": {
        "id": "6b5c3d47-47ec-3907-8654-881a64296321",
        "contentType": "STORY",
        "title": "Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases",
        "description": "",
        "summary": "LA JOLLA, Calif., September 02, 2025--Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals",
        "pubDate": "2025-09-02T13:00:00Z",
        "displayTime": "2025-09-02T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/05897a27b5d4a3514b8d5aa21ac571b1",
          "originalWidth": 480,
          "originalHeight": 221,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYdiL_1kyM4_FolGDwwueQ--~B/aD0yMjE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/05897a27b5d4a3514b8d5aa21ac571b1.cf.webp",
              "width": 480,
              "height": 221,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ye8Mf1.FGNRrrle.pnoA2g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/05897a27b5d4a3514b8d5aa21ac571b1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/enlaza-therapeutics-announces-strategic-collaboration-130000070.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/enlaza-therapeutics-announces-strategic-collaboration-130000070.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]